A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

NCT05557045 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

332

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Metastatic Cancer
Solid Tumor

Interventions

DRUG: JZP815

Sponsor

Jazz Pharmaceuticals